Volume 19, Number 7—July 2013
Unique Clone of Coxiella burnetii Causing Severe Q Fever, French Guiana
Highlight and copy the desired format.
|EID||Mahamat A, Edouard S, Demar M, Abboud P, Patrice J, La Scola B, et al. Unique Clone of Coxiella burnetii Causing Severe Q Fever, French Guiana. Emerg Infect Dis. 2013;19(7):1102-1104. https://dx.doi.org/10.3201/eid1907.130044|
|AMA||Mahamat A, Edouard S, Demar M, et al. Unique Clone of Coxiella burnetii Causing Severe Q Fever, French Guiana. Emerging Infectious Diseases. 2013;19(7):1102-1104. doi:10.3201/eid1907.130044.|
|APA||Mahamat, A., Edouard, S., Demar, M., Abboud, P., Patrice, J., La Scola, B....Raoult, D. (2013). Unique Clone of Coxiella burnetii Causing Severe Q Fever, French Guiana. Emerging Infectious Diseases, 19(7), 1102-1104. https://dx.doi.org/10.3201/eid1907.130044.|
Acute Q fever is an emergent and severe disease in French Guiana. We obtained 5 Coxiella burnetii isolates from samples of patients from Cayenne and found an epidemic clone circulating in Cayenne. This clone has caused pneumonia and endocarditis and seems to be more virulent than previously described strains.
Q fever, which is caused by the bacterium Coxiella burnetii, has rapidly emerged in French Guiana since 1996 (1). The incidence of acute Q fever in the capital, Cayenne, is one of the highest in the world. The annual incidence of Q fever was estimated at 37 cases/100,000 persons in 1996 (2) and increased to 150 cases/100,000 persons in 2005 (3). The most common clinical feature of Q fever in Cayenne is pneumonia, and C. burnetii is the causative agent of 24% of all community-acquired pneumonias (4). These forms of acute Q fever are particularly severe (4). Subsequently, we have hypothesized the existence of a specific source of C. burnetii responsible for human infections, which is unidentified to date, and the existence of a different strain of C. burnetii that circulates in Cayenne.
Q fever is diagnosed by serologic analysis in Cayenne. C. burnetii is rarely identified by PCR and has yet to be cultured in Cayenne. In this study, we isolated 5 C. burnetii strains from biologic samples of patients from Cayenne. We compared the strains from Cayenne with other strains and showed that a unique genotype is circulating in Cayenne. This unique genotype might be related to the clinical and epidemiologic features of severe fever in Cayenne.
As a national reference center for Q fever, our center receives samples from France and other regions for serologic, molecular, histologic, and immunohistochemical analyses as described (5–7). In 2012, we received a cardiac valve sample from a patient in Cayenne with Q fever endocarditis who had undergone surgery in Martinique. In the same year, we collected 4 heparinized blood samples from patients with acute Q fever from Cayenne that were collected before initiation of antimicrobial drug treatment.
The patient in Cayenne who had endocarditis was a 60-year-old man. Serologic titers of IgG1 increased to 51,200 in this patient, and results of quantitative PCR (qPCR) and immunohistochemical analyses of the valvular sample were positive for C. burnetii (Figure 1). The other 4 patients (2 men and 2 women) had fever and acute pneumonia, and 2 of them also had increased transaminase levels. All 4 patients had serologic titers compatible with acute Q fever. The heparinized blood samples were tested by using a specific qPCR; samples from only 1 patient were positive for C. burnetii.
All samples were cultured as described (8). We successfully cultured C. burnetii from the valvular sample after incubation for 16 days and from 3 blood samples after incubation for 25, 32, and 32 days. Paradoxically, the only blood sample that was positive by qPCR was negative by culture. Genotyping was performed by using multispacer sequence typing for intergenic regions (9). We identified the isolate from the cardiac valve as genotype 17. Spacers Cox 51 and Cox 20 were the most discriminating spacers in identifying this genotype, and the 3 isolates from the blood cultures were also identified by these 2 spacers as genotype 17 (Figure 2). This genotype had been identified in our laboratory only once, in 2000 in an aortic valve of a 40-year-old French man who had undergone surgery in France, had Q fever endocarditis, and was co-infected with Streptococcus oralis. Retrospectively, we found that patient had lived in Cayenne for years before his diagnosis with Q fever endocarditis. Therefore, all genotype 17 isolates were obtained from who lived or had lived in Cayenne, making it unique to this area. We determined the antimicrobial drug susceptibilities of these isolates, and the MIC of doxycycline was 0.25 µg/mL for all isolates (10).
For the past 10 years, routine cell culture for C. burnetii has been performed in our laboratory. We found that the proportion of isolates obtained from blood samples of patients with acute Q fever was higher for patients from Cayenne than for patients from metropolitan France. We obtained 3 isolates from 5 blood samples from untreated patients in Cayenne and 3 isolates from 65 samples from patients in metropolitan France (p = 0.003, by Fisher exact test). However, we did not find any difference with respect to the culture delay between patients from the 2 locations.
Our work shows that genotype 17, a unique genotype, is circulating in Cayenne. This genotype is related to genotypes that harbor the QpH1 plasmid, which causes the most severe clinical forms of acute Q fever in experimental animal models (11,12). Only bacteria from this group and bacteria containing the QpDV plasmid have been found in cases of human acute Q fever (9,13). We believe that severity of Q fever infection is related to the strain of C. burnetii circulating in Cayenne. Because the population in French Guiana is a large diversity of Creole, Amerindian, Maroon, Caucasian, and Asian persons (14), we excluded the hypothesis that genetic susceptibility of patients from Cayenne to C. burnetii infection might be related to severity of the disease.
We observed a higher rate of strain isolation from the blood of patients from Cayenne than from the blood of patients from metropolitan France. This difference may be related to a higher bacterial load in blood or a greater ability of the bacteria to grow on cell cultures. This second hypothesis seems more likely because even if the observed delay for the first culture was the same for genotype 17 and other genotypes, the strain from Cayenne was isolated more frequently in the cell line that we used (HEL cells) than other strains of C. burnetii from France. In addition, we did not find a higher number of DNA copies in the blood of patients from Cayenne, and qPCR results were not correlated with culture results.
C. burnetii isolates from Cayenne were susceptible to antimicrobial drugs, particularly doxycycline. These isolates cause acute pneumonia and endocarditis. Among the 34 genotypes identified in our study by multispacer sequence typing, 28 (82%) were associated with disease in humans. A larger biodiversity of strains has been observed in samples from patients in metropolitan France (9), where 21 genotypes circulate (Figure 2). In contrast, during the recent Q fever outbreak in the Netherlands, it appears that a single strain (genotype 33) was responsible for the epidemic (15). We believe that there has been an epidemic developing in Cayenne since 1996 that is caused primarily, if not solely, by a single strain that has circulated since at least 2000, whose reservoir is unknown (1,2).
In conclusion, C. burnetii genotype 17 is circulating in French Guiana and causing acute infections and endocarditis. This strain is epidemic and most likely causes more acute infections with exacerbated immune responses than other known genotypes of C. burnetii. Genotype 17 might be the most virulent genotype of C. burnetii described to date.
Dr Mahamat is an infectious diseases physician and head of the infection control unit at the General Hospital of Cayenne, French Guiana. His research interests include emerging disease surveillance, outbreak reports and quasi-experimental studies using times series analysis.
We thank Vanessa Cingala and Arthur Derour-Corthe for providing support, Sylvain Buffet for designing the phylogenetic tree and providing sequence analysis, and Hubert Lepidi for performing immunohistochemical analysis.
- Pfaff F, Francois A, Hommel D, Jeanne I, Margery J, Guillot G, Q fever in French Guiana: new trends. Emerg Infect Dis. 1998;4:131–2.
- Gardon J, Heraud JM, Laventure S, Ladam A, Capot P, Fouquet E, Suburban transmission of Q fever in French Guiana: evidence of a wild reservoir. J Infect Dis. 2001;184:278–84.
- Grangier C, Debin M, Ardillon V, Mahamat A, Fournier P, Simmonnet C. Epidemiology of Q fever in in Guyana, 1990–2006 [in French]. Bulletin de Veille Sanitaire. 2009.
- Epelboin L, Chesnais C, Boulle C, Drogoul AS, Raoult D, Djossou F, Q fever pneumonia in French Guiana: high prevalence, risk factors and prognostic score. Clin Infect Dis. 2012;55:67–74.
- Fournier PE, Thuny F, Richet H, Lepidi H, Casalta JP, Arzouni JP, Comprehensive diagnostic strategy for blood culture-negative endocarditis: a prospective study of 819 new cases. Clin Infect Dis. 2010;51:131–40.
- Fournier PE, Marrie TJ, Raoult D. Diagnosis of Q fever. J Clin Microbiol. 1998;36:1823–34 .
- Lepidi H, Houpikian P, Liang Z, Raoult D. Cardiac valves in patients with Q fever endocarditis: microbiological, molecular, and histologic studies. J Infect Dis. 2003;187:1097–106.
- Raoult D, Vestris G, Enea M. Isolation of 16 strains of Coxiella burnetii from patients by using a sensitive centrifugation cell culture system and establishment of the strains in HEL cells. J Clin Microbiol. 1990;28:2482–4 .
- Glazunova O, Roux V, Freylikman O, Sekeyova Z, Fournous G, Tyczka J, Coxiella burnetii genotyping. Emerg Infect Dis. 2005;11:1211–7 .
- Boulos A, Rolain JM, Maurin M, Raoult D. Measurement of the antibiotic susceptibility of Coxiella burnetii using real time PCR. Int J Antimicrob Agents. 2004;23:169–74.
- Russell-Lodrigue KE, Andoh M, Poels MW, Shive HR, Weeks BR, Zhang GQ, Coxiella burnetii isolates cause genogroup-specific virulence in mouse and guinea pig models of acute Q fever. Infect Immun. 2009;77:5640–50.
- Samuel JE, Frazier ME, Mallavia LP. Correlation of plasmid type and disease caused by Coxiella burnetii. Infect Immun. 1985;49:775–9 .
- Angelakis E, Million M, D’Amato F, Rouli L, Richet H, Stein A, Q fever and pregnancy: disease, prevention, and strain specificity. Eur J Clin Microbiol Infect Dis. 2013;32:361–8.
- Mahamat A, Louvel D, Vaz T, Demar M, Nacher M, Djossou F. High prevalence of HBsAg during pregnancy in Asian communities at Cayenne Hospital, French Guiana. Am J Trop Med Hyg. 2010;83:711–3.
- Tilburg JJ, Roest HJ, Buffet S, Nabuurs-Franssen MH, Horrevorts AM, Raoult D, Epidemic genotype of Coxiella burnetii among goats, sheep, and humans in the Netherlands. Emerg Infect Dis. 2012;18:887–9 .
- Figure 1. . . Immunohistochemical detection of Coxiella burnetii in resected cardiac valve of a 60-year-old man with Q fever endocarditis, Cayenne, French Guiana. Monoclonal antibody against C. burnetii and hematoxylin...
- Figure 2. . . Phylogenetic diversity of 34 genotypes of Coxiella burnetii identified by using multispacer sequence typing (MST). Clone from French Guiana isolated in this study is indicated in boldface....
1These authors contributed equally to this article.
Please use the form below to submit correspondence to the authors or contact them at the following address:
Didier Raoult, Faculté de Médecine, Université de la Méditeraranée, 27 Bd Jean Moulin, 13385 Marseille Cedex 5, France
Comment submitted successfully, thank you for your feedback.
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
- Page created: May 24, 2013
- Page last updated: June 17, 2013
- Page last reviewed: June 17, 2013
- Centers for Disease Control and Prevention,
National Center for Emerging and Zoonotic Infectious Diseases (NCEZID)
Office of the Director (OD)